RxDoctor Payments Data

Michelle Cochran

Family · Silver Spring, MDNPI 1366790644

Payments from drug & device makers

$408in general payments, 2019–2025

Across 11 payments — averaging $37.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Radius Health, Inc.$108
  • Amgen$66
  • Novo Nordisk$45
  • Gilead$42
  • Pfizer$42
  • AbbVie$34
  • plus $70 from 3 others

What the payments were for

  • Food & beverage$408100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Radius Health, Inc.1$108
Amgen1$66
Novo Nordisk1$45
Gilead2$42
Pfizer2$42
AbbVie1$34
Exact Sciences1$30
GSK1$24
Sanofi1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$408 in reported general payments places this provider in the 50th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$88,896
Medicare patients
218
Services billed
3,873

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium31$923
Atorvastatin Calcium78$844
Amlodipine Besylate43$311
Lisinopril27$268
Tamsulosin Hcl11$255
Losartan Potassium29$247
Hydrochlorothiazide14$156
Levothyroxine Sodium23$149
Metoprolol Tartrate12$58

Paid to pharmacies, not to this prescriber.

Other family in Silver Spring

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →